These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Oral contraceptives and venous thromboembolic disease: the findings from database studies in the United Kingdom and Germany. Farmer RD, Lawrenson RA. Am J Obstet Gynecol; 1998 Sep; 179(3 Pt 2):S78-86. PubMed ID: 9753314 [Abstract] [Full Text] [Related]
6. The risks of venous thromboembolic disease among German women using oral contraceptives: a database study. Farmer RD, Todd JC, Lewis MA, MacRae KD, Williams TJ. Contraception; 1998 Feb; 57(2):67-70. PubMed ID: 9589831 [Abstract] [Full Text] [Related]
7. The use of oral contraceptives and the occurrence of acute myocardial infarction in young women. Results from the Transnational Study on Oral Contraceptives and the Health of Young Women. Lewis MA, Heinemann LA, Spitzer WO, MacRae KD, Bruppacher R. Contraception; 1997 Sep; 56(3):129-40. PubMed ID: 9347202 [Abstract] [Full Text] [Related]
11. Venous thromboembolism and desogestrel- or gestodene-containing combination oral contraceptives: what are the facts? Contracept Rep; 1996 Apr; 7(1):3-6. PubMed ID: 12320047 [Abstract] [Full Text] [Related]
12. The increased risk of venous thromboembolism and the use of third generation progestagens: role of bias in observational research. The Transnational Research Group on Oral Contraceptives and the Health of Young Women. Lewis MA, Heinemann LA, MacRae KD, Bruppacher R, Spitzer WO. Contraception; 1996 Jul; 54(1):5-13. PubMed ID: 8804801 [Abstract] [Full Text] [Related]
16. Smoking and use of oral contraceptives: impact on thrombotic diseases. Lidegaard O. Am J Obstet Gynecol; 1999 Jun 11; 180(6 Pt 2):S357-63. PubMed ID: 10368521 [Abstract] [Full Text] [Related]